A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The researchers are doing this study to find out whether the combination of pembrolizumab and
cryoablation is a safe treatment that causes few or mild side effects in people with
mesothelioma. The researchers will also look at whether the combination of pembrolizumab and
cryoablation is effective against participants' cancer.